Central Statistical Monitoring

Detect Unknown Clinical Trial Issues

Central Statistical Monitoring Screenshot
1
Analysis Results

Intelligent Grouping of analysis results based on machine learning.

2
Data Analysis

Analyse all Clinical and Operational data.

3
Compare Performance

See individual performance against overall site performance.

Hover over the toggles to discover the features.
FIND ATYPICAL SITES FAST

Central Statistical Monitoring can uncover unknown problems in the execution of your clinical trial. Use CSM to identify which Patients, Sites and/or Countries/Regions have atypical data patterns that lead to the discovery of operational issues.

Connect with an Expert
Central Statistical Monitoring Screenshot
1
Analysis Results

Intelligent Grouping of analysis results based on machine learning.

2
Data Analysis

Analyse all Clinical and Operational data.

3
Compare Performance

See individual performance against overall site performance.

Hover over the toggles to discover the features.
  • Test all data you collect, both clinical and operational for issues
  • Review the trending of results to identify improving or worsening scenarios
  • Drill-down to the underlying data to ask further questions
  • Manage all findings to conclusion in a unified issue management environment
  • Uncover issues missed by other data quality control techniques
  • Target your analysis to the data that matters
  • Leverage machine learning to expedite the results to the study team
  • Detect fraudulent patients or patient-related data
  • Detect sloppiness in data recording, such as data propagation, rounding or digit preference
  • Detect systemic errors in data recording, such as issues with medical equipment
  • Detect rater bias or training issues
  • Detect data timeliness issues such as implausible data accrual rates

Got a Question?

Whether you’re looking to get started or need support, we’re here to help!

Featured Whitepaper

ICH E6 (R2)
Summary
Paper

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)
Webinar
Series

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.

2,500

Platform Users

350

Studies De-Risked

15,000

Issues Detected